1-6 of 6
Priya Sriskandarajah
Close
Sort by
Journal Articles

Enhanced Cardiovascular Risk Assessment Incorporating Natural Language Processing and Qrisk-3 Score Determination in Patients with Essential Thrombocythaemia

Patrick Harrington, Andrea Duminuco, Joshua Au Yeung, Sukhraj Singh Virdee, Raj Vaghela, Susan Asirvatham, Rosemarie Bone, Claire Woodley, Kyaw Htin Thaw, Llywelyn Cadman-Davies, Jennifer O'Sullivan, Priya Sriskandarajah, Natalia Curto-Garcia, Shahram Kordasti, Hugues de Lavallade, Deepti H. Radia, James Teo, Claire N Harrison
Journal: Blood
Blood (2023) 142 (Supplement 1): 4561.
https://doi.org/10.1182/blood-2023-180536
Published: 2023
Journal Articles

A Snapshot Audit of Symptom Burden in Patients with Indolent Systemic Mastocytosis Utilising the ISM-SAF © within a UK Centre of Excellence: Guy's and St Thomas' NHS Foundation Trust

Scott Veitch, Susan Asirvatham, Priya Sriskandarajah, Chandan Saha, Clare Oni, Clive Grattan, Deepti H. Radia
Journal: Blood
Blood (2023) 142 (Supplement 1): 4579.
https://doi.org/10.1182/blood-2023-188777
Published: 2023
Journal Articles

The Use of Avapritinib in Advanced Systemic Mastocytosis: Report of an Open-Label Compassionate Use Program in the United Kingdom

Christopher J. Saunders, Chandan Saha, Priya Sriskandarajah, Helen Cashman, Andrew J Wilson, Jonathan Lambert, Matthew Lawes, David Tucker, Simone Green, Manish Jain, Victoria Stables, Juanah Addada, Theingi Yin, Huw Roddie, Bethan Psaila, Deepti H. Radia
Journal: Blood
Blood (2022) 140 (Supplement 1): 3976–3977.
https://doi.org/10.1182/blood-2022-166073
Published: 2022
Journal Articles

'Application of Prognostic Scoring in Systemic Mastocytosis Patients within a UK Centre of Excellence: Guys and St Thomas' NHS Foundation Trust.'

Priya Sriskandarajah, Clare Oni, Claire Woodley, Susan Asirvatham, Monika Ciesielska, Chienye Asinobi, Rebecca Todd, Natalia Curto-Garcia, Jennifer O'Sullivan, Chandan Saha, Thompson Olaoni, Anna Green, Yurina Miki, Mark Ong, Donal P McLornan, Claire N. Harrison, Clive Grattan, Deepti H. Radia
Journal: Blood
Blood (2021) 138 (Supplement 1): 3625.
https://doi.org/10.1182/blood-2021-152234
Published: 2021
Journal Articles

Update on Clinical Safety and Efficacy of the Novel Oral Dual RAF/MEK Inhibitor RO5126766 (CH5127566) in RAS- mutant Multiple Myeloma

Priya Sriskandarajah, MBBS, BSc, MRCP, Kevin Boyd, Wen Xu, MD, Irene Moreno Candilejo, MD, Sidra Ellis, Amy Price, Amy L Sherborne, PhD, James Croft, MBBS, BSc, Vallari Shah, MBBS, Joanna Dawes, PhD, Mona Parmar, Alison Turner, Emma Hall, BSc, MSc, PhD, Nina Tunariu, MBBS, MDes, MRCP, FRCR, Juanita S Lopez, MB BChir, MRCP, PhD, Johann S. de Bono, Udai Banerji, MBBS, MD DNB, PhD FRCP, Martin Kaiser, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3237.
https://doi.org/10.1182/blood-2018-99-111821
Published: 2018
Journal Articles

Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment

Charlotte Pawlyn, Mohid S. Khan, Ann Muls, Priya Sriskandarajah, Martin F. Kaiser, Faith E. Davies, Gareth J. Morgan, H. Jervoise N. Andreyev
Journal: Blood
Blood (2014) 124 (15): 2467–2468.
https://doi.org/10.1182/blood-2014-06-583302
Published: 2014